The phase 1/2 study will assess next-generation immunotherapy alone and in combination with an immune checkpoint inhibitor in ...

Investigators said patients experienced adverse effects in line with those expected for myeloablative conditioning with ...

Anocca has submitted its first clinical trial application (CTA) to the European Medicines Agency (EMA) for conducting the ...

Neoantigen DNA vaccines are safe and capable of inducing neoantigen-specific immune responses in patients with triple-negative breast cancer.

The approval is supported by data from the COBLT study, FDA dockets and public information, and an observational database.

Medical experts and thalassemia advocates are urging the Indian government to mandate nucleic acid amplification testing (NAT ...

Every three minutes, an American is diagnosed with some type of blood cancer and every nine minutes, an American is lost.

Infections in the lower urinary tract rarely migrate to the kidneys, but the precise mechanism that the human body employs to ...